目前尚不清楚 DUPIXENT 对 1 岁以下或体重低于 33 磅(15 公斤)的嗜酸细胞性食管炎儿童是否安全有效。 (5) 用于治疗成人结节性痒疹 (PN)。目前尚不清楚 DUPIXENT 对 18 岁以下患有结节性痒疹的儿童是否安全有效。 参考来源:‘Dupixent® (dupilumab) approved in the US as first and only treatment for ado...
Treatment CRSwNP with antibiotics 青云英语翻译 请在下面的文本框内输入文字,然后点击开始翻译按钮进行翻译,如果您看不到结果,请重新翻译! 翻译结果1翻译结果2翻译结果3翻译结果4翻译结果5 翻译结果1复制译文编辑译文朗读译文返回顶部 用抗生素治疗鼻息肉 翻译结果2复制译文编辑译文朗读译文返回顶部...
2024年09月13日 (纽约州塔里敦和巴黎) 再生元(Regeneron Pharmaceuticals)和赛诺菲(Sanofi)宣布,美国FDA已批准其药品Dupixent(dupilumab)作为病情不能充分控制的慢性鼻窦炎伴鼻息肉(CRSwNP)12至17岁青少年患者的辅助维持治疗。 Dupixent为美国FDA批准针对此类CRSwNP患者群体的首个治疗方案。 此次获批主要获得来自两项成人CRS...
a请您稍等一会, 正在翻译,请等待...[translate] aTreatment with topical antibiotics in CRSwNP 治疗与典型抗生素在CRSwNP[translate]
Real world data on the treatment of CRSwNP with dupilumabdoi:10.1055/s-0043-1767569Heubisch, SydneyPlinkert, PeterBock, MaxBaumann, IngoSalzmann, IrinaLaryngo-Rhino-Otologie
Treatment Modalities In CRSsNP and CRSwNPロイコトリエン受容体拮抗薬クロモグリク酸ナトリウム小児喘息交叉比較試験QOLdoi:10.1474/Epitome.04.0354.Geoitalia2011D. Hamilos日本小児アレルギー学会誌 = The Japanese journal of pediatric allergy and clinical immunology...
et al. Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature. Eur Arch Otorhinolaryngol 281, 5023–5031 (2024). https://doi.org/10.1007/s00405-024-08725-7 Download citation Received14 April 2024 Accepted04 May 2024 Published19 May...
To present current evidence in long-term (> 5 years) results after endoscopic sinus surgery (ESS) focusing on Patients Reported Outcome Measures (PROMs) and other sinonasal outcomes while assessing the role of ESS in the treatment of CRSwNP, and identifying outcomes which affect the results of...
This study aimed to evaluate the effectiveness and safety of dupilumab during the first year of treatment in a real-life setting, focusing on improvement i... C Galletti,M Ragusa,F Sireci,... - American Journal of Otolaryngology--Head and Neck Medicine and Surgery 被引量: 0发表: 2024年 ...
Combination endoscopic sinus surgery (ESS) and biological therapy significantly decreased polyp burden in refractory chronic rhinosinusitis with nasal polyposis (CRSwNP) compared with biologic therapy alone Treatment with biologic therapy in combination with surgery for patients with refractory chronic ...